N/A
N=28
Cognitive-Behavioral Therapy for Weight-related Bullying (Online Treatment)
Bullying · Weight, Body · Trauma, Psychological
Bottom Line
View on ClinicalTrials.gov: NCT04587752 ↗Enrolled (actual)
28
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Stress — 20.55 units on a scale — p=.047
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- CBT for Weight Bullying (Behavioral)
- Age
- Pediatric · 11+ yrs
- Sex
- Female
- Sponsor
- Yale University
- Primary completion
- Aug 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Stress |
20.55 | .047 sig |
| SECONDARY Body Dissatisfaction |
2.85 | .01 sig |
| SECONDARY Overvaluation |
1.93 | <.001 sig |
Summary
This study will perform a clinical trial with adolescents to pilot a new cognitive-behavioral treatment (CBT) for weight-related bullying testing (1) feasibility, (2) acceptability, and (3) initial efficacy. The treatment will be conducted via audio/video telehealth.
Eligibility Criteria
Inclusion Criteria: To be included, adolescents must:
- Be in the age range ≥11 years old and ≤17 years old;
- Report experiencing weight-related bullying
- Report current distress about weight-related bullying
- Be otherwise-healthy youth (i.e., no uncontrolled or serious medical conditions);
- Read, comprehend, and write English at a sufficient level to complete study-related materials;
- Located in the United States and available for participation in the study for 3 months.
Exclusion Criteria: Prospective participants will be excluded if the adolescent:
- Has a medical or psychiatric condition that would require hospitalization or intensive care (e.g., severe anorexia, neurological disorder, psychotic disorders, suicidality);
- Has uncontrolled medical condition(s) (e.g., uncontrolled diabetes or hypertension);
- Is pregnant or breastfeeding;
- Is taking medication(s) or participating in treatment(s) that could influence weight or appetite;
- Is engaged in concurrent treatments that focus on trauma-related stress;
- Began taking hormonal contraceptives less than 3 months prior;
- Has a developmental or cognitive disorder (e.g., autism spectrum disorder);
- Has avoidant/restrictive food intake disorder; or
- Is participating in another clinical research study.
Data sourced from ClinicalTrials.gov (NCT04587752). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.